Left Ventricular Assist Devices On The Market And In Development
This article was originally published in The Gray Sheet
You may also be interested in...
Developing medical technologies exclusively for children has not typically been an easy or profitable path to tread
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.
Dozens of life science companies are working to find effective treatments for COVID-19. In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into some of the efforts that are under way on this front.